Citation Information :
Narkhede H, Asalkar MR, Munload S, Vipulachandra Y, Patil TV. Vertical Transmission of SARS-CoV-2 to Newborns in COVID-19 Infected Mothers: A Cross-sectional Study. J South Asian Feder Obs Gynae 2021; 13 (4):230-235.
Aim and objective: To establish the presence or absence of vertical transmission of SARS-CoV-2 in patients who delivered during the study period.
Study design: Cross-sectional study was conducted from May 2020 to October 2020 at dedicated COVID hospital. During the study period, all SARS-CoV-2-positive patients who delivered at the study institution were studied to find SARS-CoV-2 infection in newborn by intrauterine transmission. Newborns were screened within 60 minutes of delivery for vertical transmission of SARS-CoV-2 infection by nasopharyngeal swab test for RT-PCR.
Results: Two hundred one COVID positive pregnant women enrolled in the study. Two newborns tested SARS-CoV-2 positive by RT-PCR test: One was delivered by vaginal route and other by caesarian section. Both babies who were tested SARS-CoV-2 positive by RT-PCR test were born after EDD (>40 weeks) to low-risk mothers. Time interval between maternal test positivity and delivery interval was 7–14 days.
Conclusion: The rate of VT is 0.99% in our study. The possibility of vertical transmission is more in postdated pregnancy. There was no relation seen in our study with the severity of disease or symptoms of infection at the time of admission and vertical transmission, but it needs to be further studied. We did not notice the association of high-risk obstetrics conditions and vertical transmission.
Fan C, Lei D, Fang C, et al. Perinatal transmission of 2019 coronavirus disease-associated severe acute respiratory syndrome coronavirus 2: should we worry? Clin Infect Dis 2021;72(5):862–864. DOI: 10.1093/cid/ciaa226.
Della Gatta AN, Rizzo R, Pilu G, et al. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol 2020;223(1):36–41. DOI: 10.1016/j.ajog.2020.04.013.
Yang Z, Wang M, Zhu Z, et al. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. J Matern Fetal Neonatal Med 2020;1–4. DOI: 10.1080/14767058.2020.1759541 [Epub ahead of print].
Yang Z, Liu Y. Vertical transmission of severe acute respiratory syndrome coronavirus 2: a systematic review. Am J Perinatol 2020;37(10):1055–1060. DOI: 10.1055/s-0040-1712161.
Lamouroux A, Attie-Bitach T, Martinovic J, et al. Evidence for and against vertical transmission for severe acute respiratory syndrome coronavirus 2. Am J Obstet Gynecol 2020;223(1):91.e1–91.e4. DOI: 10.1016/j.ajog.2020.04.039.
Wang C, Zhou YH, Yang HX, et al. Intrauterine vertical transmission of SARS-CoV-2: what we know so far. Ultrasound Obstet Gynecol 2020;55(6):724–725. DOI: 10.1002/uog.22045.
Vivanti AJ, Vauloup-Fellous C, Prevot S, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020;11:3572. DOI: 10.1038/s41467-020-17436-6.
Fermin G. Chapter 5 – host range, host–virus interactions, and virus transmission. In: Tennant P, Fermin G, Foster JE, editors. Viruses. Academic Press; 2018. p. 101–134.
Blumberg DA, Underwood MA, Hedriana HL, et al. Vertical transmission of SARS-CoV-2: what is the optimal definition? Am J Perinatol 2020;37(8):769–772. DOI: 10.1055/s-0040-1712457.
Dong L, Tian J, He S, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 2020;323(18):1846–1848. DOI: 10.1001/jama.2020.4621.
Schwartz DA, Morotti D, Beigi B, et al. Confirming vertical fetal infection with coronavirus disease 2019: neonatal and pathology criteria for early onset and transplacental transmission of severe acute respiratory syndrome coronavirus 2 from infected pregnant mothers. Arch Pathol Lab Med 2020;144(12):1451–1456. DOI: 10.5858/arpa.2020-0442-SA.
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet (London, England) 2020;395(10226):809–815. DOI: 10.1016/S0140-6736(20)30360-3.
Zeng L, Xia S, Yuan W, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 2020;174(7):722–725. DOI: 10.1001/jamapediatrics.2020.0878.
Pettirosso E, Giles M, Cole S, et al. COVID-19 and pregnancy: a review of clinical characteristics, obstetric outcomes and vertical transmission. Aust N Z J Obstet Gynaecol 2020;60(5):640–659. DOI: 10.1111/ajo.13204.
Ashraf MA, Keshavarz P, Hosseinpour P, et al. Coronavirus disease 2019 (COVID-19): a systematic review of pregnancy and the possibility of vertical transmission. J Reprod Infertil 2020;21(3):157–168. PMCID: PMC7362089.
Nayak AH, Kapote DS, Fonseca M, et al. Impact of the coronavirus infection in pregnancy: a preliminary study of 141 patients. J Obstet Gynaecol India 2020;70(4):256–261. DOI: 10.1007/s13224-020-01335-3.
Schwartz DA, Mohagheghi P, Beigi B, et al. Spectrum of neonatal COVID-19 in Iran: 19 infants with SARS-CoV-2 perinatal infections with varying test results, clinical findings and outcomes. J Matern Fetal Neonatal Med 2020;1–10. DOI: 10.1080/14767058.2020. 1797672.
Patanè L, Morotti D, Giunta MR, et al. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth. Am J Obstet Gynecol MFM 2020;2(3):100145. DOI: 10.1016/j.ajogmf.2020.100145.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183 [Erratum in: Lancet 2020. PMID: 31986264; PMCID: PMC7159299].
Pringle KG, Tadros MA, Callister RJ, et al. The expression and localization of 74 the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in 75 trophoblast invasion and angiogenesis? Placenta 2011;32(12):956–962. DOI: 10.1016/j.placenta.2011.09.020.
Li M, Chen L, Zhang J, et al. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 2020;15(4):e0230295. DOI: 10.1371/journal.pone.0230295.
Stagno S, Tinker MK, Elrod C, et al. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and new-born infant. J Clin Microbiol 1985;21(6):930–935. DOI: 10.1128/jcm.21.6.930-935.1985.
Yu N, Li W, Kang Q, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single centre, descriptive study. Lancet Infect Dis 2020;20(5):559–564. DOI: 10.1016/S1473-3099(20)30176-6.
Fenizia C, Biasin M, Cetin I, et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun 2020;11(1):5128. DOI: 10.1038/s41467-020-18933-4.
Yang R, Mei H, Zheng T, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC Med 2020;18(1):330. DOI: 10.1186/s12916-020-01798-1.
Di Mascio D, Sen C, Saccone G, et al. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. J Perinat Med 2020;49(1):111–115. DOI: 10.1515/jpm-2020-0539.